KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Inventory (2016 - 2026)

Lam Research has reported Inventory over the past 17 years, most recently at $4.0 billion for Q1 2026.

  • For Q1 2026, Inventory fell 10.38% year-over-year to $4.0 billion; the TTM value through Mar 2026 reached $4.0 billion, down 10.38%, while the annual FY2025 figure was $4.3 billion, 2.14% up from the prior year.
  • Inventory for Q1 2026 was $4.0 billion at Lam Research, down from $4.0 billion in the prior quarter.
  • Over five years, Inventory peaked at $4.9 billion in Q1 2023 and troughed at $3.5 billion in Q1 2022.
  • A 5-year average of $4.3 billion and a median of $4.3 billion in 2024 define the central range for Inventory.
  • Biggest five-year swings in Inventory: soared 56.79% in 2022 and later dropped 12.42% in 2024.
  • Year by year, Inventory stood at $4.8 billion in 2022, then fell by 8.09% to $4.4 billion in 2023, then decreased by 1.62% to $4.4 billion in 2024, then dropped by 7.35% to $4.0 billion in 2025, then dropped by 0.93% to $4.0 billion in 2026.
  • Business Quant data shows Inventory for LRCX at $4.0 billion in Q1 2026, $4.0 billion in Q4 2025, and $4.1 billion in Q3 2025.